Patent ID: 6946121

Claim:
A method for inhibiting the granulation and/or degranulation of white blood cells in a patient, comprising the topical external administration of a composition, wherein the composition comprises: an oligosaccharide of formula I, which is the active principle, containing from three to five saccharide units and having at least one D-galactose unit linked via an α[1-6] bond with a sucrose unit: in which R 1 , R 2 , R 3 and R 4 represent, independently of each other, a hydrogen atom, an alkyl group containing from 1 to 10 carbon atoms and optionally having at least one unsaturation, an acid function containing from 1 to 10 carbon atoms and optionally having at least one unsaturation, and a sulfate function or a monosaccharide; and a molecule that is positively charged at physiological pH and promotes pinocytosis, or a molecule that promotes membrane penetration; wherein the composition is administered in an amount sufficient to inhibit the granulation and/or degranulation of white blood cells in the patient.